BioCorRx Inc.
corporate_fare Company Profile
BioCorRx Inc. (OTC:BICX) is a publicly traded company in the Industrial Applications And Services sector. Wiseek monitors BICX SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- BioCorRx Reports Q1 2026 Results: Revenue Up 59%, Cash Burn Improves Amidst Ongoing Going Concern
- BioCorRx Issues 2.26M Shares to Insiders for Full Subsidiary Control, Diluting Shareholders
- BioCorRx Reports Going Concern, Revenue Surge from Lucemyra Acquisition, and Insider Stock Purchase
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$797.24K
Net Income
-$3.44M
Diluted EPS
-$0.19
Op. Cash Flow
-$2.3M
Operating Income
-$4.83M
Cash & Equivalents
$139.36K
Debt / Equity
0.00×
Net Margin
-431.5%
Shares Outstanding
24.49M sh
Source: 10-K · filed 2026-03-31 · accession 0001477932-26-001807
show_chartPrice Chart
Loading chart...
feed BICX - Latest Insights
BICX
May 15, 2026, 9:31 AM EDT
Price at Filing:
$0.409463
Real-time Price:
$0.380
Change:
-$0.029463 (-7%)
Market Cap:
$11.041M
BICX
Apr 02, 2026, 3:31 PM EDT
Price at Filing:
$0.400
Real-time Price:
$0.380
Change:
-$0.020 (-5%)
Market Cap:
$11.041M
BICX
Mar 31, 2026, 3:04 PM EDT
Price at Filing:
$0.400
Real-time Price:
$0.380
Change:
-$0.020 (-5%)
Market Cap:
$11.041M